BIOMAT Database Logo BIOMAT Database Logo

Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice. 1992

Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden.

Mouse plasmacytomas induced by pristane oil alone, or in combination with Abelson murine leukemia virus (A-MuLV), regularly carry one of three alternative chromosomal translocations that juxtapose c-myc to immunoglobulin heavy- or light-chain loci. E mu-c-myc transgenic mice develop translocation-free plasmacytomas after induction by pristane oil and/or A-MuLV [Sugiyama, H., Silva, S., Wang, Y., Weber, G., Babonits, M., Rosen, A., Wiener, F. & Klein, G. (1990). Int. J. Cancer, 46, 845-852]. In order to test whether another member of the myc family, N-myc, could play a similar role as c-myc, we treated E mu-N-myc transgenic mice with pristane and helper-free A-MuLV. Of 20 mice that received a single pristane injection followed by A-MuLV, 17 developed plasmacytomas with a mean latency period of 54 +/- 20 days. In a corresponding group that only received a single pristane injection, five out of six transgenic mice developed plasmacytomas with a mean latency period of 142 +/- 32 days. However, after three monthly injections of pristane, all 15 transgenic mice developed plasmacytomas with a mean latency period of 128 +/- 20 days. All plasmacytomas expressed the N-myc transgene, while none of them expressed either c-myc or endogenous N-myc. None of the tumors carried the usual plasmacytoma-associated translocations.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004742 Enhancer Elements, Genetic Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter. Enhancer Elements,Enhancer Sequences,Element, Enhancer,Element, Genetic Enhancer,Elements, Enhancer,Elements, Genetic Enhancer,Enhancer Element,Enhancer Element, Genetic,Enhancer Sequence,Genetic Enhancer Element,Genetic Enhancer Elements,Sequence, Enhancer,Sequences, Enhancer
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene

Related Publications

Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis.
February 1987, Science (New York, N.Y.),
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Immunoglobulin genes and the c-myc oncogene in plasmacytomagenesis.
March 1986, The Mount Sinai journal of medicine, New York,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
February 1989, Cell,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation.
June 2000, Genes & development,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
October 1986, Cell,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
August 1996, Cancer letters,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
The c-myc proto-oncogene regulates cardiac development in transgenic mice.
July 1990, Molecular and cellular biology,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
January 1997, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
May 1992, Oncogene,
Y Wang, and H Sugiyama, and H Axelson, and C K Panda, and M Babonits, and A Ma, and J M Steinberg, and F W Alt, and G Klein, and F Wiener
Differential expression of myc-family genes during development: normal and deregulated N-myc expression in transgenic mice.
January 1988, Current topics in microbiology and immunology,
Copied contents to your clipboard!